Catalyst Wire Dossier Catalyst Wire Dossier

Menomune

Meningococcal polysaccharide vaccine (serogroups A, C, W, Y) · Sanofi Pasteur
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Menomune, covering 2009-04-30 to 2012-06-19. Get the full timeline:

Most recent: Clinical Trial Update: Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination [Phase 2]

See pricing